Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research.
Highlighting the principle of using a prophylactic vaccine in the midst of a pandemic. Likely to create more more viral variants in the process.
Subjects: Lockdowns - Gaining immunity from exposure & immunological escape - COVID vaccine - COVID antibodies - NK Cells - Antigen-specific antibodies outcompete natural antibodies - Highly-infectious strain - Vaccine resistance in COVID pandemic - More on immunological escape - Geert Vanden Bossche’s thoughts on COVID vaccination
Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research. Coordinated Global Alliance for Vaccines and Immunisation's Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA) and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates. Sharing his perspective on mass vaccination in COVID-19.
Learn more about autoimmunity in COVID-19. https://mcmillanresearch.com/
_____
Geert Vanden Bossche & Peter McCullough Webinar: Presentation by Geert Vanden Bossche
This is the presentation by Geert Vanden Bossche, DVM, PhD about the risk of “viral escape” posed by “leaky vaccines.”
The theoretical article he is referring to is: https://journals.plos.org/plosbiology...
You can find many more info and references on his website: https://www.geertvandenbossche.org/
See more at http://covexit.com
No comments:
Post a Comment